Development of a contemporary globally diverse HIV viral panel by the EQAPOL program

Journal of Immunological Methods

Volumn 409, Issue , 2014, Pages 117-130

  Sanchez, Ana M ^a   DeMarco, C Todd ^a   Hora, Bhavna ^a   Keinonen, Sarah ^a   Chen, Yue ^a   Brinkley, Christie ^a   Stone, Mars ^b   Tobler, Leslie ^b   Keating, Sheila ^b   Schito, Marco ^c   Busch, Michael P ^b   Gao, Feng ^a   Denny, Thomas N ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

EQAPOL; HIV; Recombinant; Subtype panel

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; REAGENT;

BLOOD DONOR; BLOOD SAMPLING; CLINICAL RESEARCH; CONTROLLED STUDY; CRYOPRESERVATION; DIAGNOSTIC TEST; EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCIENTIST; SEROCONVERSION; SUPERNATANT; UNINDEXED SEQUENCE; VACCINE PRODUCTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EQAPOL; HIV; RECOMBINANT; SUBTYPE PANEL;

AIDS VACCINES; BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CYTOKINES; GENOTYPE; GUIDELINE ADHERENCE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC TESTS; INTERNATIONAL COOPERATION; LABORATORY PROFICIENCY TESTING; LEUKOCYTES, MONONUCLEAR; MONITORING, IMMUNOLOGIC; OBSERVER VARIATION; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUALITY CONTROL; QUALITY INDICATORS, HEALTH CARE; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906095368     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.01.004     Document Type: Review

References (63)

1. Adazu K., Lindblade K.A., Rosen D.H., Odhiambo F., Ofware P., Kwach J., Van Eijk A.M., Decock K.M., Amornkul P., Karanja D., Vulule J.M., Slutsker L. Health and demographic surveillance in rural western Kenya: a platform for evaluating interventions to reduce morbidity and mortality from infectious diseases. Am. J. Trop. Med. Hyg. 2005, 73:1151.
2. Aguado-Martinez A., Alvarez-Garcia G., Fernandez-Garcia A., Risco-Castillo V., Marugan-Hernandez V., Ortega-Mora L.M. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Vaccine 2009, 27:7331.
3. Albert J., Gaines H., Sonnerborg A., Nystrom G., Pehrson P.O., Chiodi F., von Sydow M., Moberg L., Lidman K., Christensson B., et al. Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J. Med. Virol. 1987, 23:67.
4. Amendola A., Coen S., Belladonna S., Pulvirenti F.R., Clemens J.M., Capobianchi M.R. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA. Clin. Chem. Lab. Med. 2011, 49:1283.
5. Antunes R., Figueiredo S., Bartolo I., Pinheiro M., Rosado L., Soares I., Lourenco H., Taveira N. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J. Clin. Microbiol. 2003, 41:3361.
6. Baalwa J., Wang S., Parrish N.F., Decker J.M., Keele B.F., Learn G.H., Yue L., Ruzagira E., Ssemwanga D., Kamali A., Amornkul P.N., Price M.A., Kappes J.C., Karita E., Kaleebu P., Sanders E., Gilmour J., Allen S., Hunter E., Montefiori D.C., Haynes B.F., Cormier E., Hahn B.H., Shaw G.M. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology 2013, 436:33.
7. Brown B.K., Darden J.M., Tovanabutra S., Oblander T., Frost J., Sanders-Buell E., de Souza M.S., Birx D.L., McCutchan F.E., Polonis V.R. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J. Virol. 2005, 79:6089.
8. Busch M.P., Pilcher C.D., Mastro T.D., Kaldor J., Vercauteren G., Rodriguez W., Rousseau C., Rehle T.M., Welte A., Averill M.D., Garcia Calleja J.M., WHO Working Group on HIV Incidence Assays Beyond detuning: 10years of progress and new challenges in the development and application of assays for HIV incidence estimation. Aids 2010, 24:2763.
9. Charneau P., Borman A.M., Quillent C., Guetard D., Chamaret S., Cohen J., Remy G., Montagnier L., Clavel F. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994, 205:247.
10. Chudy M., Weber-Schehl M., Pichl L., Jork C., Kress J., Heiden M., Funk M.B., Nubling C.M. Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets. Transfusion 2012, 52:431.
11. Coombs R.W., Welles S.L., Hooper C., Reichelderfer P.S., D'Aquila R.T., Japour A.J., Johnson V.A., Kuritzkes D.R., Richman D.D., Kwok S., Todd J., Jackson J.B., DeGruttola V., Crumpacker C.S., Kahn J. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J. Infect. Dis. 1996, 174:704.
12. Corbet S., Muller-Trutwin M.C., Versmisse P., Delarue S., Ayouba A., Lewis J., Brunak S., Martin P., Brun-Vezinet F., Simon F., Barre-Sinoussi F., Mauclere P. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J. Virol. 2000, 74:529.
13. Costa C.I., Morgado M.G., Santos V.G., Bongertz V. HIV-1 isolation from plasma specimens. Memorias do Instituto Oswaldo Cruz 1996, 91:745.
14. Cuevas M.T., Fernandez-Garcia A., Pinilla M., Garcia-Alvarez V., Thomson M., Delgado E., Gonzalez-Galeano M., Miralles C., Serrano-Bengoechea E., Ojea de Castro R., Lopez-Alvarez M.J., Lezaun M.J., Sanchez-Garcia A.M., Sanchez-Martinez M., Munoz-Nieto M., Perez-Alvarez L. Short communication: biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment. AIDS Res. Hum. Retroviruses 2010, 26:1019.
15. De Bel A., Marissens D., Debaisieux L., Liesnard C., Van den Wijngaert S., Lauwers S., Pierard D. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay. J. Clin. Microbiol. 2010, 48:1337.
16. Delgado E., Fernandez-Garcia A., Vega Y., Cuevas T., Pinilla M., Garcia V., Sanchez M., Gonzalez M., Sanchez A.M., Thomson M.M., Perez-Alvarez L. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes. J. Antimicrob. Chemother. 2012, 67:25.
17. Diez-Fuertes F., Delgado E., Vega Y., Fernandez-Garcia A., Cuevas M.T., Pinilla M., Garcia V., Perez-Alvarez L., Thomson M.M. Improvement of HIV-1 coreceptor tropism prediction by employing selected nucleotide positions of the env gene in a Bayesian network classifier. J. Antimicrob. Chemother. 2013, 68:1471.
18. Falk L.A., Paul D., Landay A., Kessler H. HIV isolation from plasma of HIV-infected persons. N. Engl. J. Med. 1987, 316:1547.
19. Fernandez-Garcia A., Cuevas M.T., Vinogradova A., Rakhmanova A., Perez-Alvarez L., de Castro R.O., Osmanov S., Thomson M.M. Near full-length genome characterization of a newly identified HIV type 1 subtype F variant circulating in St. Petersburg, Russia. AIDS Res. Hum. Retroviruses 2009, 25:1187.
20. Fernandez-Garcia A., Perez-Alvarez L., Cuevas M.T., Delgado E., Munoz-Nieto M., Cilla G., Iribarren J.A., Pinilla M., Ocampo A., Miralles C., Perez-Castro S., Gonzalez-Galeano M., de Castro R.O., Trigo M., Garcia V., Sanchez A.M., Thomson M.M. Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. AIDS Res. Hum. Retroviruses 2010, 26:827.
21. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., Heldebrant C., Smith R., Conrad A., Kleinman S.H., Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. Aids 2003, 17:1871.
22. Gottesman B.S., Grossman Z., Lorber M., Levi I., Shitrit P., Katzir M., Shahar E., Gottesman G., Chowers M. Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. J. Med. Virol. 2006, 78:883.
23. Greco G., Barker E., Levy J.A. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. AIDS Res. Hum. Retroviruses 1998, 14:1407.
24. Hemelaar J., Gouws E., Ghys P.D., Osmanov S., WHO-UNAIDS Network for HIV Isolation and Characterisation Global trends in molecular epidemiology of HIV-1 during 2000-2007. Aids 2011, 25:679.
25. Huang D.D., Giesler T.A., Bremer J.W. Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. AIDS Res. Hum. Retroviruses 2003, 19:321.
26. Jiang C., Parrish N.F., Wilen C.B., Li H., Chen Y., Pavlicek J.W., Berg A., Lu X., Song H., Tilton J.C., Pfaff J.M., Henning E.A., Decker J.M., Moody M.A., Drinker M.S., Schutte R., Freel S., Tomaras G.D., Nedellec R., Mosier D.E., Haynes B.F., Shaw G.M., Hahn B.H., Doms R.W., Gao F. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J. Virol. 2011, 85:10669.
27. Kim J.E., Beckthold B., Chen Z., Mihowich J., Malloch L., Gill M.J. Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. AIDS Res. Hum. Retroviruses 2007, 23:1309.
28. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 1980, 16:111.
29. Korber B.T., Osmanov S., Esparza J., Myers G. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO network for HIV isolation and characterization. AIDS Res. Hum. Retroviruses 1994, 10:1355.
30. Li M., Gao F., Mascola J.R., Stamatatos L., Polonis V.R., Koutsoukos M., Voss G., Goepfert P., Gilbert P., Greene K.M., Bilska M., Kothe D.L., Salazar-Gonzalez J.F., Wei X., Decker J.M., Hahn B.H., Montefiori D.C. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 2005, 79:10108.
31. Ly T.D., Ebel A., Faucher V., Fihman V., Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?. J. Virol. Methods 2007, 143:86.
32. Ly T.D., Plantier J.C., Leballais L., Gonzalo S., Lemee V., Laperche S. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J. Clin. Virol. 2012, 55:121.
33. Manak M., Sina S., Anekella B., Hewlett I., Sanders-Buell E., Ragupathy V., Kim J., Vermeulen M., Stramer S.L., Sabino E., Grabarczyk P., Michael N., Peel S., Garrett P., Tovanabutra S., Busch M.P., Schito M. Pilot studies for development of an HIV subtype panel for surveillance of global diversity. AIDS Res. Hum. Retroviruses 2012, 28:594.
34. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167.
35. O'Brien T.R., Blattner W.A., Waters D., Eyster E., Hilgartner M.W., Cohen A.R., Luban N., Hatzakis A., Aledort L.M., Rosenberg P.S., Miley W.J., Kroner B.L., Goedert J.J. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996, 276:105.
36. O'Connell R.J., Kim J.H., Corey L., Michael N.L. Human immunodeficiency virus vaccine trials. Cold Spring Harbor perspectives in medicine 2012, 2:a007351.
37. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 2000, 74:10074.
38. Piot P., Quinn T.C. Response to the AIDS pandemic-a global health model. New Engl. J. Med. 2013, 368:2210.
39. Plantier J.C., Leoz M., Dickerson J.E., De Oliveira F., Cordonnier F., Lemee V., Damond F., Robertson D.L., Simon F. A new human immunodeficiency virus derived from gorillas. Nat. Med. 2009, 15:871.
40. Price M.A., Rida W., Mwangome M., Mutua G., Middelkoop K., Roux S., Okuku H.S., Bekker L.G., Anzala O., Ngugi E., Stevens G., Chetty P., Amornkul P.N., Sanders E.J. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J. Acquir. Immune Defic. Syndr. 2012, 59:185.
41. Price M.A., Wallis C.L., Lakhi S., Karita E., Kamali A., Anzala O., Sanders E.J., Bekker L.G., Twesigye R., Hunter E., Kaleebu P., Kayitenkore K., Allen S., Ruzagira E., Mwangome M., Mutua G., Amornkul P.N., Stevens G., Pond S.L., Schaefer M., Papathanasopoulos M.A., Stevens W., Gilmour J., I.E.I.C.S.Group Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res. Hum. Retroviruses 2011, 27:5.
42. Ragupathy V., Zhao J., Wood O., Tang S., Lee S., Nyambi P., Hewlett I. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virol. J. 2011, 8:185.
43. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4:406.
44. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H., Parrish N.F., Shaw K.S., Guffey M.B., Bar K.J., Davis K.L., Ochsenbauer-Jambor C., Kappes J.C., Saag M.S., Cohen M.S., Mulenga J., Derdeyn C.A., Allen S., Hunter E., Markowitz M., Hraber P., Perelson A.S., Bhattacharya T., Haynes B.F., Korber B.T., Hahn B.H., Shaw G.M. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206:1273.
45. Schultz A.K., Zhang M., Bulla I., Leitner T., Korber B., Morgenstern B., Stanke M. jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res. 2009, 37:W647.
46. Schultz A.K., Zhang M., Leitner T., Kuiken C., Korber B., Morgenstern B., Stanke M. A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinforma. 2006, 7:265.
47. Shimizu N., Tanaka A., Oue A., Mori T., Ohtsuki T., Apichartpiyakul C., Uchiumi H., Nojima Y., Hoshino H. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS 2009, 23:761.
48. Simon F., Mauclere P., Roques P., Loussert-Ajaka I., Muller-Trutwin M.C., Saragosti S., Georges-Courbot M.C., Barre-Sinoussi F., Brun-Vezinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 1998, 4:1032.
49. Spira A.I., Ho D.D. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 1995, 69:422.
50. Stramer S.L., Caglioti S., Strong D.M. NAT of the United States and Canadian blood supply. Transfusion 2000, 40:1165.
51. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Sally C., Wright D.J., Dodd R.Y., Busch M.P. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N. Engl. J. Med. 2004, 351:760.
52. Tang J., Cormier E., Gilmour J., Price M.A., Prentice H.A., Song W., Kamali A., Karita E., Lakhi S., Sanders E.J., Anzala O., Amornkul P.N., Allen S., Hunter E., Kaslow R.A., IAVI African HIV Research Network Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J. Virol. 2011, 85:88-94.
53. Todd C.A., et al. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). J. Immunol. Methods 2014, 409:91-98.
54. Thomson M.M., Fernandez-Garcia A., Delgado E., Vega Y., Diez-Fuertes F., Sanchez-Martinez M., Pinilla M., Castro M.A., Marino A., Ordonez P., Ocampo A., da Silva A.R., Perez-Castro S., Lopez-Alvarez M.J., Trigo M., Perez-Alvarez L. Rapid expansion of a HIV-1 subtype F cluster of recent origin among men who have sex with men in Galicia, Spain. J. Acquir. Immune Defic. Syndr. 2012, 59:e49.
55. UNAIDS Report on the Global AIDS Epidemic 2012.
56. Vallejo A., Gurtler L., Zekeng L., Hewlett I.K. Nucleotide sequence analysis of the accessory genes of HIV-1 group O isolates. Virus Res. 2003, 91:189.
57. Walker C.M., Moody D.J., Stites D.P., Levy J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563.
58. Welles S.L., Jackson J.B., Yen-Lieberman B., Demeter L., Japour A.J., Smeaton L.M., Johnson V.A., Kuritzkes D.R., D'Aquila R.T., Reichelderfer P.A., Richman D.D., Reichman R., Fischl M., Dolin R., Coombs R.W., Kahn J.O., McLaren C., Todd J., Kwok S., Crumpacker C.S. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J. Infect. Dis. 1996, 174:696.
59. WHO Progress Report 2011: Global HIV/AIDS Response 2011.
60. Williams L.M., Cloyd M.W. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 1991, 184:723.
61. Xu S., Song A., Li X., Nie J., Zhang C., Wang Y. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5. Intervirology 2010, 53:221.
62. Zhao J., Tang S., Ragupathy V., Gaddam D., Wang X., Zhang P., Nyambi P.N., Hewlett I. CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon. J. Acquir. Immune Defic. Syndr. 2012, 60:344.
63. Zou S., Musavi F., Notari E.P., Stramer S.L., Dodd R.Y. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion 2010, 50:1487.